您的位置:PharmaNews 市场快讯 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

Access Pharmaceuticals to Host North American MuGard Commercialization Update Conference Call for Investors(2)
本文章共2195字,分2页,当前第2页,快速翻页:


 


  Contact: Company              Contact: Investor Relations
  ----------------              ---------------------------
                                  Donald C. Weinberger/Diana Bittner
  Christine Berni                (media)
  Director of Investor Relations Wolfe Axelrod Weinberger Assoc. LLC
  Access Pharmaceuticals, Inc.  (212) 370-4500
  (212) 786-6208

Source: Access Pharmaceuticals, Inc.

CONTACT: Christine Berni, Director of Investor Relations of Access
Pharmaceuticals, Inc., +1-212-786-6208; or Investor Relations, Donald C.
Weinberger/Diana Bittner (media) of Wolfe Axelrod Weinberger Assoc. LLC,
+1-212-370-4500, for Access Pharmaceuticals, Inc.
 

Web Site: http://www.accesspharma.com/

 

转载自pharmaLive


 

 

点这里复制本页地址     发送给您QQ/MSN上的好友


相关文章

  MCOs Offering Both Medicare Advantage an

  Sun Pharma: US Appeals Court Rules Gemza

  Marketing Disease Prevention In America

  Purdue Archives and Special Collections

Actient Pharmaceuticals, LLC Closes Tran

Health Secretary Urges All Pennsylvanian

Sanofi Pasteur Begins Shipping Influenza

GlaxoSmithKline Begins Distribution of F

Perrigo Confirms Filing for Generic Vers

全球气温飙升,清凉油出口井喷

相关评论

    
本文章所属分类:首页 市场快讯